New Silver-Infused dressing aims to ease pain and speed healing after HS surgery
NCT ID NCT07316192
First seen Jan 08, 2026 · Last updated May 24, 2026 · Updated 19 times
Summary
This study tests whether a new wound dressing called Pelashield PainGuard helps people heal better after surgery for hidradenitis suppurativa (HS) compared to the current standard dressing, Restrata. Pelashield contains silver to fight bacteria and lidocaine to reduce pain. Ten adults with severe HS who need surgery will be enrolled, and their results will be compared to past patients who used Restrata. The goal is to see if the new dressing leads to less pain, fewer infections, and faster healing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital
RECRUITINGNewark, New Jersey, 07103, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.